Position in VCYT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,073,752
+$1,196,650 QoQ
Shares Held
52,337
-10.2% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#107
of 367 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $22,849,574 across 11 Diagnostics & Research names. VCYT ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDNT |
RadNet, Inc.
|
116,506 | $7,184,925 | |
| 2 | TWST |
Twist Bioscience Corp
|
53,282 | $5,481,652 | |
| 3 | NEO |
Neogenomics Inc
|
223,846 | $3,265,913 | |
| 4 | VCYT |
Veracyte, Inc.
This page
|
52,337 | $3,073,752 | |
| 5 | DGX |
Quest Diagnostics Inc
|
4,281 | $907,357 | |
| 6 | CSTL |
Castle Biosciences Inc
|
31,748 | $757,189 | |
| 7 | GRAL |
GRAIL, Inc.
|
8,696 | $593,675 | |
| 8 | MYGN |
Myriad Genetics Inc
|
97,375 | $556,011 |
All Filings in VCYT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,073,752 | 52,337 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,877,102 | 58,277 | Shares | Sole | 2026-04-28 | |
| 2024-12-31 | $1,375,902 | 34,745 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $5,815,189 | 170,834 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,358,405 | 62,686 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $197,268 | 8,902 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $38,205 | 1,500 | Shares | Sole | 2023-07-11 | |
| No filing history on record for this holder in this stock. | ||||||